Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ulla Airaksinen is active.

Publication


Featured researches published by Ulla Airaksinen.


Journal of Bacteriology | 2001

Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis.

Marika Vitikainen; Tiina Pummi; Ulla Airaksinen; Eva Wahlström; Hongyan Wu; Matti Sarvas; Vesa P. Kontinen

Regulated expression of AmyQ alpha-amylase of Bacillus amyloliquefaciens was used to examine the capacity of the protein secretion apparatus of B. subtilis. One B. subtilis cell was found to secrete maximally 10 fg of AmyQ per h. The signal peptidase SipT limits the rate of processing of the signal peptide. Another limit is set by PrsA lipoprotein. The wild-type level of PrsA was found to be 2 x 10(4) molecules per cell. Decreasing the cellular level of PrsA did not decrease the capacity of the protein translocation or signal peptide processing steps but dramatically affected secretion in a posttranslocational step. There was a linear correlation between the number of cellular PrsA molecules and the number of secreted AmyQ molecules over a wide range of prsA and amyQ expression levels. Significantly, even when amyQ was expressed at low levels, overproduction of PrsA enhanced its secretion. The finding is consistent with a reversible interaction between PrsA and AmyQ. The high cellular level of PrsA suggests a chaperone-like function. PrsA was also found to be essential for the viability of B. subtilis. Drastic depletion of PrsA resulted in altered cellular morphology and ultimately in cell death.


Clinical and Vaccine Immunology | 2003

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing Immune Responses in the Experimental Infection Model

Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M. Vuola; Mirja Puolakkainen; Matti Sarvas

ABSTRACT Due to intracellular growth requirements, large-scale cultures of chlamydiae and purification of its proteins are difficult and laborious. To overcome these problems we produced chlamydial proteins in a heterologous host, Bacillus subtilis, a gram-positive nonpathogenic bacterium. The genes of Chlamydia pneumoniae major outer membrane protein (MOMP), the cysteine-rich outer membrane protein (Omp2), and the heat shock protein (Hsp60) were amplified by PCR, and the PCR products were cloned into expression vectors containing a promoter, a ribosome binding site, and a truncated signal sequence of the α-amylase gene from Bacillus amyloliquefaciens. C. pneumoniae genes were readily expressed in B. subtilis under the control of the α-amylase promoter. The recombinant proteins MOMP and Hsp60 were purified from the bacterial lysate with the aid of the carboxy-terminal histidine hexamer tag by affinity chromatography. The Omp2 was separated as an insoluble fraction after 8 M urea treatment. The purified proteins were successfully used as immunogens and as antigens in serological assays and in a lymphoproliferation test. The Omp2 and Hsp60 antigens were readily recognized by the antibodies appearing after pulmonary infection following intranasal inoculation of C. pneumoniae in mice. Also, splenocytes collected from mice immunized with MOMP or Hsp60 proteins proliferated in response to in vitro stimulation with the corresponding proteins.


Biotechnology Letters | 2002

Candidaguilliermondii grows on rare pentoses – implications for production of pure xylitol

Tom Granström; Ulla Airaksinen; XiaoYan Wu; Matti Leisola

Feeding sucrose at 20 g l -1 on day 16 gave maximum paclitaxel production at 10 mg l -1 when Taxus chinensis in 5 I bioreactors, Paclitaxel accumulation was doubled by the cultivation of cells initially with dissolved O 2 tension at 60% for 20 days followed by being at 20% for another 12 days in the bioreactor. Combination of these two strategies gave maximum paclitaxel production of 19 mg l -1 after 32 days.


Microbial Pathogenesis | 1991

Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis

Rose-Marie Ölander; Anna Muotiala; Juha-Pekka Himanen; Marjatta Karvonen; Ulla Airaksinen; Kate Runeberg-Nyman

Pertussis toxin (PT) subunit S1 was produced in Bacillus subtilis as a secretory protein designated BacS1. BacS1 was partially purified and used to immunize mice. The sera were tested for PT-neutralizing antibodies and for protective capacity in a mouse model. Unlike previous findings with recombinant S1 from Escherichia coli, the recombinant BacS1 protein induced antibodies that were both neutralizing and protective. An adjuvant was necessary for efficient immunization with BacS1 but not with PT. Of the four adjuvants tested, aluminium phosphate gel was insufficient whereas Freunds incomplete adjuvant, Klebsiella lipopolysaccharide and Ribis monophosphoryl lipid A-trehalose dimycolate emulsion all resulted in protective antibody production in NIH mice.


Biotechnology Letters | 1991

Expression of the outer membrane protein P.69 ofBordetella pertussis inBacillus subtilis

Ulla Airaksinen; Per E. J. Saris; Kate Runeberg-Nyman; Ilkka Palva

SummaryThe gene coding forBordetella pertussis P.69 protein was cloned and expressed inBacillus subtilis. The expression vector contained the promoter region and the sequence coding for the whole or truncated signal sequence of the α-amylase gene fromB. amyloliquefaciens. Using either construction the level of expression was relatively low and the protein was found in the particulate fraction. The protein migrated in gel electrophoresis slower than expected from its deduced amino acid content thereby giving the appearance of having an anomalously large molecular mass.


Applied and Environmental Microbiology | 1999

Exopolysaccharide-Producing Bacteria from Sugar Beets

Antti H. Tallgren; Ulla Airaksinen; Robert von Weissenberg; Heikki Ojamo; Juhani Kuusisto; Matti Leisola


Journal of Biotechnology | 2005

Improved mannitol production by a random mutant of Leuconostoc pseudomesenteroides.

Miia Helanto; Johannes Aarnikunnas; Niklas von Weymarn; Ulla Airaksinen; Airi Palva; Matti Leisola


Archive | 1994

Xylose utilization by recombinant yeasts

Johan Hallborn; Merja Penttilä; Heikki Ojamo; Mats Walfridsson; Ulla Airaksinen; Sirkka Keränen; Bärbel Hahn-Hägerdal


Fems Microbiology Letters | 1990

Production and secretion of pertussis toxin subunits in Bacillus subtilis

Per E. J. Saris; Suvi Taira; Ulla Airaksinen; Airi Palva; Matti Sarvas; Ilkka Palva; Kate Runeberg-Nyman


Archive | 1999

Production of ethanol from xylose

Johan Hallborn; Merja Penttilä; Heikki Ojamo; Mats Walfridsson; Ulla Airaksinen; Sirkka Keränen; Bärbel Hahn-Hägerdal

Collaboration


Dive into the Ulla Airaksinen's collaboration.

Top Co-Authors

Avatar

Heikki Ojamo

Helsinki University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Merja Penttilä

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar

Sirkka Keränen

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matti Leisola

Helsinki University of Technology

View shared research outputs
Top Co-Authors

Avatar

Airi Palva

University of Helsinki

View shared research outputs
Top Co-Authors

Avatar

Niklas von Weymarn

Helsinki University of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge